METTL1 and metabolic dysfunction-associated steatotic liver disease: This study presents our findings on METTL1 modified human umbilical cord MSCs, emphasizing their therapeutic effects and the mechanisms involved in treating MASLD.<h4>Methods</h4>METTL1 knockdown MSCs were generated via lentiviral shRNA.